Home Cart 0 Sign in  
X

[ CAS No. 40492-52-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 40492-52-2
Chemical Structure| 40492-52-2
Chemical Structure| 40492-52-2
Structure of 40492-52-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 40492-52-2 ]

Related Doc. of [ 40492-52-2 ]

Alternatived Products of [ 40492-52-2 ]

Product Details of [ 40492-52-2 ]

CAS No. :40492-52-2 MDL No. :MFCD09029838
Formula : C8H8O2 Boiling Point : -
Linear Structure Formula :- InChI Key :JNYKOGUXPNAUIB-UHFFFAOYSA-N
M.W : 136.15 Pubchem ID :11126311
Synonyms :

Calculated chemistry of [ 40492-52-2 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.25
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 37.81
TPSA : 29.46 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.87 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.55
Log Po/w (XLOGP3) : 1.78
Log Po/w (WLOGP) : 1.33
Log Po/w (MLOGP) : 1.09
Log Po/w (SILICOS-IT) : 2.06
Consensus Log Po/w : 1.56

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.25
Solubility : 0.766 mg/ml ; 0.00563 mol/l
Class : Soluble
Log S (Ali) : -2.02
Solubility : 1.31 mg/ml ; 0.00962 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.08
Solubility : 1.13 mg/ml ; 0.00828 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.6

Safety of [ 40492-52-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 40492-52-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 40492-52-2 ]
  • Downstream synthetic route of [ 40492-52-2 ]

[ 40492-52-2 ] Synthesis Path-Upstream   1~21

  • 1
  • [ 13196-10-6 ]
  • [ 40492-52-2 ]
YieldReaction ConditionsOperation in experiment
51% With hydrogen In ethanol for 19 h; B.
2,3-Dihydro-benzofuran-5-ol.
To a solution of Benzofuran-5-ol (300 mg; 2.24 mmol) in ethanol (10 mL) was added 10percent Pd-C (20 mg) and the mixture was shaken under 50 psi hydrogen atmosphere in a Parr hydrogenator for 19 h.
The reaction was filtered and concentrated to give a crude material.
The crude material was recrystallized from toluene twice.
The solid was collected by vacuum filtration and dried to give the title compound (155 mg; 51percent yield).
1H NMR (400 MHz, CDCl3): δ 6.71-6.75 (m, 1H), 6.62-6.66 (m, 1H), 6.55-6.60 (m, 1H), 4.54 (t, 2H), 4.35 (s, 1H), 3.18 (t, 2H).
Reference: [1] Patent: US2011/105527, 2011, A1, . Location in patent: Page/Page column 18
  • 2
  • [ 13391-30-5 ]
  • [ 40492-52-2 ]
YieldReaction ConditionsOperation in experiment
38% With boron tribromide In dichloromethane at -60 - 20℃; for 17 h; To a solution of Example 2d (43.1 g, 0.29 mol) in DCM (800 mL) at -60 °C was added BBr3 (215 mL, 1M in DCM) dropwise. The reaction mixture was allowed to stir at room temperature for 17 h. The reaction mixture was quenched slowly with MeOH (200 mL), and basified with NaHC03 to pH~8. The organic layer was separated, dried over Na2S04, filtrated and concentrated under reduced pressure. The residue was purified by silica gel chromatography, eluting with 10percent of EtOAc in Petroleum Ether, to give the desired product (Example 2e, 14.8 g, yield 38percent) as white solid. 1H NMR (400 MHz, DMSO) δ 8.76 (s, 1H), 6.59 (d, J= 8.5 Hz, 1H), 6.51 (d, J= 2.8 Hz, 1H), 6.46 (dd, J = 8.5, 2.9 Hz, 1H), 3.60 (t, J= 7.6 Hz, 2H), 2.96 (t, J= 7.6 Hz, 2H).
Reference: [1] Patent: WO2017/218960, 2017, A1, . Location in patent: Paragraph 00384
[2] Patent: WO2010/127208, 2010, A1, . Location in patent: Page/Page column 60-61
  • 3
  • [ 90843-31-5 ]
  • [ 40492-52-2 ]
Reference: [1] Patent: WO2011/20848, 2011, A1, . Location in patent: Page/Page column 30
[2] Patent: EP2289889, 2011, A1, . Location in patent: Page/Page column 15
  • 4
  • [ 4082-30-8 ]
  • [ 40492-52-2 ]
Reference: [1] Journal of Organic Chemistry, 2001, vol. 66, # 15, p. 4965 - 4972
  • 5
  • [ 130933-04-9 ]
  • [ 40492-52-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 276 - 281
  • 6
  • [ 7417-19-8 ]
  • [ 40492-52-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 276 - 281
  • 7
  • [ 1758-25-4 ]
  • [ 40492-52-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 276 - 281
  • 8
  • [ 99187-42-5 ]
  • [ 40492-52-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 276 - 281
  • 9
  • [ 119795-46-9 ]
  • [ 40492-52-2 ]
  • [ 119794-84-2 ]
  • [ 119795-45-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1989, vol. 32, # 5, p. 1006 - 1020
  • 10
  • [ 13391-28-1 ]
  • [ 40492-52-2 ]
Reference: [1] Patent: US2011/105527, 2011, A1,
  • 11
  • [ 13391-35-0 ]
  • [ 40492-52-2 ]
Reference: [1] Journal of Organic Chemistry, 2001, vol. 66, # 15, p. 4965 - 4972
  • 12
  • [ 584-82-7 ]
  • [ 40492-52-2 ]
Reference: [1] Journal of Organic Chemistry, 2001, vol. 66, # 15, p. 4965 - 4972
  • 13
  • [ 2503-23-3 ]
  • [ 40492-52-2 ]
Reference: [1] Journal of Organic Chemistry, 2001, vol. 66, # 15, p. 4965 - 4972
  • 14
  • [ 736985-50-5 ]
  • [ 40492-52-2 ]
Reference: [1] Journal of Organic Chemistry, 2001, vol. 66, # 15, p. 4965 - 4972
  • 15
  • [ 783332-86-5 ]
  • [ 40492-52-2 ]
Reference: [1] Journal of Organic Chemistry, 2001, vol. 66, # 15, p. 4965 - 4972
  • 16
  • [ 496-16-2 ]
  • [ 40492-52-2 ]
Reference: [1] Synthesis, 1988, # 12, p. 950 - 952
  • 17
  • [ 64010-12-4 ]
  • [ 40492-52-2 ]
Reference: [1] Synthesis, 1988, # 12, p. 950 - 952
  • 18
  • [ 150-76-5 ]
  • [ 40492-52-2 ]
Reference: [1] Patent: WO2017/218960, 2017, A1,
  • 19
  • [ 17332-11-5 ]
  • [ 40492-52-2 ]
Reference: [1] Patent: WO2017/218960, 2017, A1,
  • 20
  • [ 76429-64-6 ]
  • [ 40492-52-2 ]
Reference: [1] Patent: WO2017/218960, 2017, A1,
  • 21
  • [ 66826-78-6 ]
  • [ 40492-52-2 ]
Reference: [1] Synthesis, 1988, # 12, p. 950 - 952
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 40492-52-2 ]

Alcohols

Chemical Structure| 1083168-69-7

[ 1083168-69-7 ]

(2,3-Dihydrobenzofuran-6-yl)methanol

Similarity: 0.97

Chemical Structure| 23681-89-2

[ 23681-89-2 ]

2,3-Dihydrobenzofuran-6-ol

Similarity: 0.97

Chemical Structure| 61439-59-6

[ 61439-59-6 ]

2-(4-(Benzyloxy)phenyl)ethanol

Similarity: 0.95

Chemical Structure| 177259-98-2

[ 177259-98-2 ]

2-(3-(Benzyloxy)phenyl)ethanol

Similarity: 0.92

Chemical Structure| 7417-18-7

[ 7417-18-7 ]

2-(2-Methoxyphenyl)ethanol

Similarity: 0.92

Related Parent Nucleus of
[ 40492-52-2 ]

Benzofurans

Chemical Structure| 230642-84-9

[ 230642-84-9 ]

4-Vinyl-2,3-dihydrobenzofuran

Similarity: 0.97

Chemical Structure| 1083168-69-7

[ 1083168-69-7 ]

(2,3-Dihydrobenzofuran-6-yl)methanol

Similarity: 0.97

Chemical Structure| 23681-89-2

[ 23681-89-2 ]

2,3-Dihydrobenzofuran-6-ol

Similarity: 0.97

Chemical Structure| 127264-14-6

[ 127264-14-6 ]

5-(2-Bromoethyl)-2,3-dihydrobenzofuran

Similarity: 0.86

Chemical Structure| 66158-96-1

[ 66158-96-1 ]

(2,3-Dihydrobenzofuran-2-yl)methanol

Similarity: 0.86